Werner Haberbosch

5.7k total citations · 1 hit paper
81 papers, 4.3k citations indexed

About

Werner Haberbosch is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Werner Haberbosch has authored 81 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 21 papers in Surgery and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Werner Haberbosch's work include Acute Myocardial Infarction Research (10 papers), Hormonal Regulation and Hypertension (9 papers) and Blood Coagulation and Thrombosis Mechanisms (8 papers). Werner Haberbosch is often cited by papers focused on Acute Myocardial Infarction Research (10 papers), Hormonal Regulation and Hypertension (9 papers) and Blood Coagulation and Thrombosis Mechanisms (8 papers). Werner Haberbosch collaborates with scholars based in Germany, United States and Switzerland. Werner Haberbosch's co-authors include Harald Tillmanns, Andreas Gardemann, Hans Hölschermann, Sandra Erbs, Volker Schächinger, Rainer Hambrecht, Andreas M. Zeiher, Detlef G. Mathey, Birgit Aßmus and Stefanie Dimmeler and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.

In The Last Decade

Werner Haberbosch

81 papers receiving 4.1k citations

Hit Papers

Intracoronary Bone Marrow... 2006 2026 2012 2019 2006 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Werner Haberbosch Germany 31 1.9k 1.3k 1.3k 1.2k 591 81 4.3k
Hyun‐Jai Cho South Korea 38 1.6k 0.8× 1.1k 0.8× 1.7k 1.3× 1.9k 1.6× 464 0.8× 166 5.0k
Dirk Walter Germany 37 2.5k 1.3× 808 0.6× 1.3k 1.1× 2.7k 2.2× 374 0.6× 91 6.2k
Micheline Duriez France 38 1.3k 0.7× 1.2k 1.0× 1.4k 1.1× 2.4k 1.9× 430 0.7× 59 5.6k
Hiroya Masaki Japan 28 1.3k 0.7× 1.2k 0.9× 1.3k 1.0× 2.5k 2.0× 386 0.7× 57 4.5k
Luis G. Melo Canada 30 1.4k 0.7× 1.3k 1.0× 730 0.6× 2.7k 2.2× 681 1.2× 50 4.6k
Wolfgang Schneider Germany 41 930 0.5× 853 0.7× 846 0.7× 1.3k 1.1× 189 0.3× 186 5.2k
Paul Kessler United States 26 1.8k 1.0× 1.5k 1.1× 1.3k 1.0× 1.9k 1.6× 703 1.2× 46 5.2k
Paul R. Crisostomo United States 37 1.1k 0.6× 1.3k 1.0× 583 0.5× 907 0.7× 258 0.4× 92 3.7k
Radia Tamarat France 25 1.0k 0.5× 1.4k 1.1× 564 0.4× 1.4k 1.2× 457 0.8× 48 3.7k
Mariann Gyöngyösi Austria 38 1.8k 1.0× 639 0.5× 2.1k 1.6× 1.7k 1.4× 456 0.8× 178 4.9k

Countries citing papers authored by Werner Haberbosch

Since Specialization
Citations

This map shows the geographic impact of Werner Haberbosch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Haberbosch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Haberbosch more than expected).

Fields of papers citing papers by Werner Haberbosch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Werner Haberbosch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Haberbosch. The network helps show where Werner Haberbosch may publish in the future.

Co-authorship network of co-authors of Werner Haberbosch

This figure shows the co-authorship network connecting the top 25 collaborators of Werner Haberbosch. A scholar is included among the top collaborators of Werner Haberbosch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Werner Haberbosch. Werner Haberbosch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Schächinger, Volker, Sandra Erbs, A. Elsasser, et al.. (2006). Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. European Heart Journal. 27(23). 2775–2783. 374 indexed citations
3.
Argstatter, Heike, Werner Haberbosch, & Hans Volker Bolay. (2006). Study of the effectiveness of musical stimulation during intracardiac catheterization. Clinical Research in Cardiology. 95(10). 514–522. 52 indexed citations
4.
Tillmanns, Harald, W. Waas, Reinhard Voß, et al.. (2005). Geschlechtsunterschiede im Kurz– und Langzeitverlauf nach perkutanen Koronarinterventionen. Herz. 30(5). 16–16. 13 indexed citations
5.
Hölschermann, Hans, Daniel J. Schuster, Behnoush Parviz, et al.. (2005). Statins prevent NF-κB transactivation independently of the IKK-pathway in human endothelial cells. Atherosclerosis. 185(2). 240–245. 65 indexed citations
6.
Hilgendorff, Anne, et al.. (2003). Statins differ in their ability to block NF-kB activation in human blood monocytes. International Journal of Clinical Pharmacology and Therapeutics. 41(9). 397–401. 105 indexed citations
7.
Haberbosch, Werner, et al.. (2002). The Stromelysin‐1 5A/6A Promoter Polymorphism Is a Disease Marker for the Extent of Coronary Heart Disease. Disease Markers. 18(3). 121–128. 30 indexed citations
9.
Haberbosch, Werner, et al.. (2000). Symptomatisches echtes Aneurysma eines Venenbypass mit Kompression des rechten Vorhofes. Zeitschrift für Kardiologie. 89(5). 418–422. 1 indexed citations
10.
Hilgendorff, Anne, et al.. (2000). SIMVASTATIN ATTENUATES VASCULAR HYPERCOAGULABILITY IN CARDIAC TRANSPLANT RECIPIENTS1. Transplantation. 69(9). 1830–1836. 29 indexed citations
11.
Langheinrich, Alexander C., Rainer M. Bohle, Thomas Dreyer, et al.. (1999). 3-Deazaadenosine Prevents Adhesion Molecule Expression and Atherosclerotic Lesion Formation in the Aortas of C57BL/6J Mice. Arteriosclerosis Thrombosis and Vascular Biology. 19(11). 2673–2679. 26 indexed citations
12.
Gardemann, Andreas, Quôc Dinh Nguyên, Norbert Katz, et al.. (1999). Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis. Atherosclerosis. 145(2). 309–314. 59 indexed citations
13.
Braun‐Dullaeus, Ruediger C., et al.. (1999). Cyclosporine-induced coronary artery constriction—dissociation between thromboxane release and coronary vasospasm. The Journal of Heart and Lung Transplantation. 18(4). 328–335. 10 indexed citations
14.
Waldecker, Bernd, et al.. (1998). Long-term follow-up after direct percutaneous transluminal coronary angioplasty for acute myocardial infarction. Journal of the American College of Cardiology. 32(5). 1320–1325. 39 indexed citations
16.
Nguyen, Quoc P., Norbert Katz, Monika Philipp, et al.. (1998). Association of the Platelet Glycoprotein IIIa PIA1/A2 Gene Polymorphism to Coronary Artery Disease but not to Nonfatal Myocardial Infarction in Low Risk Patients. Thrombosis and Haemostasis. 80(8). 214–217. 47 indexed citations
17.
Tillmanns, Harald, et al.. (1998). Störungen der Mikrozirkulation bei der koronaren Herzkrankheit. Zeitschrift für Kardiologie. 87(14). s026–s032. 1 indexed citations
18.
Dietz, Rainer, et al.. (1992). [Reparative effects of ACE inhibitors on the heart].. PubMed. 69 Suppl 29. 16–24. 1 indexed citations
19.
Haberbosch, Werner, Raffaele De Simone, Rainer Dietz, et al.. (1991). Improvement of Diastolic Filling in Hypertensive Patients Treated with Cilazapril. Journal of Cardiovascular Pharmacology. 17(Supplement 2). S159–S162. 8 indexed citations
20.
Gnasso, Agostino, et al.. (1986). Effect of Gemfibrozil on lipids, apoproteins, and postheparin lipolytic activities in normolipidemic subjects. Metabolism. 35(5). 387–393. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026